Role of dietary fiber in formation and prevention of small intestinal ulcers induced by nonsteroidal anti-inflammatory drug

Current Pharmaceutical Design

Volumn 16, Issue 10, 2010, Pages 1209-1213

  Satoh, Hiroshi ^a  

^a KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Cat; Cellulose; Dietary fiber; Guar gum; Indomethacin; Intestinal ulcer; NSAID; Pectin

Indexed keywords

CELLULOSE; GUAR GUM; INDOMETACIN; MUCIN; NONSTEROID ANTIINFLAMMATORY AGENT; PECTIN;

DIETARY FIBER; DUODENUM ULCER; FEEDING; FOOD COMPOSITION; HUMAN; INTESTINE MOTILITY; NONHUMAN; PRIORITY JOURNAL; REVIEW; STOMACH PROTECTION; STOMACH ULCER; ULCEROGENESIS;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DIETARY FIBER; EATING; GASTROINTESTINAL MOTILITY; HUMANS; INDOMETHACIN; INTESTINAL DISEASES; INTESTINE, SMALL; SOLUBILITY; ULCER;

EID: 77950889715     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161210790945922     Document Type: Review

References (38)

1. Brodie DA, Cook PG, Bauer BJ, Dagle GE. Indomethacin-induced intestinal lesions in the rats. Toxicol Appl Pharmacol 1970; 17: 615-624
2. Langman MJS, Morgan L, Worrall A. Use of anti-inflammatory drugs by patients admitted with small or large bowel perforations and haemorrhage. Br Med J 1985; 290: 347-349
3. Bjarnason I, Zanelli G, Smith T, Prouse P, Williams P, Smethurst P, et al. Nonsteroidal anti-inflammatory drug-induced intestinal inflammation in humans. Gastroenterology 1987; 93: 480-489
4. Allison MC, Howatson AG, Torrance CJ, Lee FD, Russell RI. Gastrointestinal damage associated with the use of nonsteroidal anti-inflammatory drugs. N Engl J Med 1992; 327: 749-754
5. Laine L, Connors LG, Reicin A, Hawkey CJ, Burgos-Vargas R, Schnitzer TJ, et al. Serious lower gastrointestinal clinical events with nonselective NSAID or coxib use. Gastroenterology 2003; 124: 288-292
6. Maiden L, Thjodleifsson B, Theodors A, Gonzalez J, Bjarnason I. A quantitative analysis of NSAID-induced small bowel pathology by capsule enteroscopy. Gastroenterology 2005; 128: 1172-1178
7. Goldstein JL, Eisen GM, Lewis B, Gralnek IM, Zlotnick S, Fort JG. Video capsule endoscopy to prospectively assess small bowel injury with celecoxib, naproxen plus omeprazole, and placebo. Clin Gastroent Hepatol 2005; 3: 133-141
8. Fortun PJ, Hawkey CJ. Nonsteroidal anti-inflammatory drugs and the small intestine. Curr Opin Gastroent 2007; 23: 134-141
9. Lanas Á, Scarpignato C. Microbial flora in NSAID-induced intestinal damage: A role for antibiotics? Digestion 2006; 73(suppl 1): 136-150.
10. Wallace JL. Nonsteroidal anti-inflammatory drugs and gastroenteropathy: The second hundred years. Gastroenterology 1997; 112: 1000-1016
11. Whittle BRJ. Mechanisms underlying intestinal injury induced by anti- inflammatory COX inhibitors. Eur J Pharmacol 2004; 500: 427-439
12. Kunikata T, Tanaka A, Miyazawa T, Kato S, Takeuchi K. 16, 16-Dimethyl prostaglandin E2 inhibits indomethacin-induced small intestinal lesions through EP3 and EP4 receptors. Dig Dis Sci 2002; 47: 894-904.
13. Anthony A, Pounder RE, Dhillon AP, Wakefield AJ. Vascular anatomy defines site of indomethacin induced jejunal ulceration along the mesenteric margin. Gut 1997; 41: 763-770
14. Miura S, Suematsu M, Tanaka S, Nagata H, Houzawa S, Suzuki M, et al. Microcirculatory disturbance in indomethacin-induced intestinal ulcer. Am J Physiol 1991; 261: G213-9.
15. Asako H, Kubes P, Wallace J, Gaginella T, Wolf RE. Indomethacin- induced leukocyte adhesion in mesenteric venules: role of lipoxygenase products. Am J Physiol 1992; 262: G903-8.
16. Robert A, Asano T. Resistance of germfree rats to indomethacin-induced intestinal lesions. Prostaglandins 1977; 14: 333-341 (Pubitemid 8171147)
17. Satoh H, Guth PH, Grossman MI. Role of bacteria in gastric ulceration produced by indomethacin in the rat: Cytoprotective action of antibiotics. Gastroenterology 1983; 84: 483-489
18. Uejima M, Kinouchi T, Kataoka K, Hiraoka I, Ohnishi Y. Role of intestinal bacteria in ileal ulcer formation in rats treated with nonsteroidal anti-inflammatory drug. Microbiol Immunol 1996; 40: 553-560 (Pubitemid 26282108)
19. Yamada T, Deitch E, Specian RD, Perry MA, Sartor RB, Grisham MB. Mechanisms of acute and chronic intestinal inflammation induced by indomethacin. Inflammation 1993; 17: 641-662 (Pubitemid 23359088)
20. Ishihara Y, Okabe S. Effects of cholestyramine and synthetic hydrotalcite on acute gastric or intestinal lesion formation in rats and dogs. Dig Dis Sci 1981; 26: 553-560 (Pubitemid 11078777)
21. Jacob M, Foster R, Sighthorsson G, Simpson R, Bjarnason I. Role of bile in pathogenesis of indomethacin-induced enteropathy. Arch Toxicol 2007; 81: 291-298 (Pubitemid 46434776)
22. Takeuchi K, Miyazawa T, Tanaka A, Kato S, Kunikata T. Pathogenic importance of intestinal hypermotility in NSAID-induced small intestinal damage in rats. Digestion 2002; 66: 30-41. (Pubitemid 36151288)
23. Tanaka A, Matsumoto M, Hayashi Y, Takeuchi K. Functional mechanism underlying cycloxygenase-2 expression in rat small intestine following administration of indomethacin: relation to intestinal hypermotility. J Gastroenterol Hepatol 2005; 20: 38-45. (Pubitemid 40143631)
24. Satoh H, Inada I, Hirata T, Maki Y. Indometacin produces gastric antral ulcers in the refed rat. Gastroenterology 1981; 81: 719-725 (Pubitemid 11014420)
25. Oi M, Ito Y, Kumagai F, Yoshida K, Tanaka Y, Yoshikawa K, et al. A possible dual control mechanism in the origin of peptic ulcer. Gastroenterology 1969; 57: 280-293
26. Satoh H, Shinoda T, Ishigami K, Nishimura S, Idaka S, Nagata M. Diets with no- or less-dietary fiber can prevent NSAID-induced intestinal ulcers in dogs and cats. Gastroenterology 2005; 128 (suppl 2): A-246 (abstract)
27. Satoh H, Shiotani S, Otsuka N, Hatao K, Nishimura S. Role of dietary fibres, intestinal motility and leukotrienes in the pathogenesis of NSAID-induced small intestinal ulcers in cats. Gut 2009; 58: 1590-1598
28. Satoh H, Guth PH, Grossman MI. Role of food in gastrointestinal ulceration produced by indomethacin in the rat. Gastroenterology 1982; 83: 210-215 (Pubitemid 12121597)
29. Matsumoto T, Iida M, Kuroki F, Hizawa K, Koga H, Fujishima M, et al. Effect of diet on experimentally induced intestinal ulcers in rats: morphology and tissue leukotrienes. Gut 1994; 35: 1058-1063 (Pubitemid 24244259)
30. Anthony A, Pounder RE, Dhillon AP, Wakefield AJ, et al. Vascular anatomy defines site of indomethacin induced jejunal ulceration along the mesenteric margin. Gut 1997; 41: 763-770 (Pubitemid 28023178)
31. Chutkan R, Toubia N. Effect of nonsteroidal anti-inflammatory drugs on the gastrointestinal tract: diagnosis by wireless capsule endoscopy. Gastrointest Endosc Clin N Am 2004; 14: 67-85. (Pubitemid 38234306)
32. Reuter BK, Davies NM, Wallace JL. Nonsteroidal anti-inflammatory drug enteropathy in rats: role of permeability, bacteria, and enterohepatic circulation. Gastroenterology 1997; 112: 109-117
33. Duggan DE, Hooke KF, Noll RM, Kwank C, et al. Enterohepatic circulation of indomethacin and its role in intestinal irritation. Biochem Pharmacol 1975; 24: 1749-1754
34. Satoh H, Hara T, Murakawa D, Matsuura M, Takata K. Soluble dietary fiber protects against nonsteroidal anti-inflammatory drug-induced damage to the small intestine in cats. Dig Dis Sci 2009; (in press).
35. Iwai T, Ichikawa T, Goso Y, Ikezawa T, Saegusa Y, Okayasu I, et al. Effects of indomethacin on the rat small intestinal mucosa: immunohistochemical and biochemical studies using anti-mucin monoclonal antibodies. J Gastroenterol 2009; 44: 277-284
36. Foti C, Bonamonte D, Conserva A, Stingeni L, Lisi P, Lionetti N, Rigano L, et al. Allergic and photoallergic contact dermatitis from ketoprofen: evaluation of cross-reactivities by a combination of photopatch testing and computerized conformational analysis. Curr Pharm Des 2008; 14(27): 2833-2839
37. Nishimori I, Onishi S, Takeuchi H, Supuran CT. The alpha and beta classes carbonic anhydrases from Helicobacter pylori as novel drug targets. Curr Pharm Des 2008; 14(7): 622-630 (Pubitemid 351736441)
38. Viola M, Quaratino D, Gaeta F, Rumi G, Caruso C, Romano A. Cross-reactive reactions to nonsteroidal anti-inflammatory drugs. Curr Pharm Des 2008; 14(27): 2826-2832